Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	84.59	76.2	71.98	94.14	68.89
Short-Term Investments	11.35	4.87	18.98	8.1	51.61
Cash & Cash Equivalents	95.94	81.07	90.96	102.24	120.49
Cash Growth	18.34%	-10.86%	-11.04%	-15.15%	-27.16%
Receivables	47.84	40.35	32.53	25.54	28.9
Inventory	7.08	4.53	7.11	3.45	3.17
Other Current Assets	5.33	8.33	9.43	14.9	13.74
Total Current Assets	156.19	134.28	140.02	146.14	166.3
Property, Plant & Equipment	8.65	12.51	15.77	18.89	21.83
Long-Term Investments	2.09	2.59	3.31	3.31	4.32
Goodwill and Intangibles	60.87	70.61	66.13	74.14	40.46
Other Long-Term Assets	2.73	2.07	1.35	1.75	2
Total Long-Term Assets	74.34	87.78	86.56	98.08	68.61
Total Assets	230.53	222.06	226.59	244.22	234.91
Accounts Payable	6.89	6.44	11.17	12.08	19.18
Current Debt	38.8	4.14	3.57	17.38	2.62
Other Current Liabilities	53.7	66.9	94.84	84.8	69.03
Total Current Liabilities	99.38	77.48	109.59	114.26	90.84
Long-Term Debt	72.69	110.14	113.07	103.57	117.61
Other Long-Term Liabilities	5.01	12.83	6.38	32.34	9
Total Long-Term Liabilities	77.7	122.97	119.45	135.92	126.61
Total Liabilities	177.09	200.45	229.03	250.17	217.44
Total Debt	111.49	114.28	116.64	120.95	120.23
Debt Growth	-2.44%	-2.02%	-3.57%	0.60%	-20.84%
Retained Earnings	-1,345.16	-1,366.76	-1,366.76	-1,337.63	-1,277.64
Comprehensive Income	-0	0	-0	0	0.06
Shareholders' Equity	53.44	21.61	-2.45	-5.95	17.46
Net Cash / Debt	-15.55	-33.21	-25.69	-18.72	0.27
Net Cash / Debt Growth	-	-	-	-	-98.04%
Net Cash Per Share	-0.33	-0.74	-0.63	-0.47	0.01
Working Capital	56.8	56.8	30.44	31.88	75.46
Book Value Per Share	1.13	0.48	-0.06	-0.15	0.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).